As of Nov 24
| +0.01 / +0.59%|
The 1 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +76.47% increase from the last price of 1.70.
The current consensus among 4 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.